In conclusion, the results of the current study allow to speculate that l-ARG might represent a potential alternative for patients with mildmoderate vasculogenic ED with contraindication to PDE5i or who had experienced adverse effects upon PDE5i treatment and might require a different therapeutic approach, or, in association to lower PDE5i doses, to reduce the occurrence and severity of PDE5i-associated adverse effects meanwhile potentially exerting an additive or synergistic effect
Another contraindication is the use of GLP-1RA in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2 (33, 34, 36)
PubMed CrossRef Lizaola-Mayo BC, Dickson RC, Lam-Himlin DM, et al
If parcel is already dispatched, customer must to contact the courier
Laville M, Nazare JA
Non-cigarette tobacco products Electronic nicotine delivery devices Cessation Data availability statement Data may be obtained from a third party and are not publicly available